Respiratory Therapies for Postoperative Lung Recovery

N/A

Recruiting

Research Sponsored by University of Texas Southwestern Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Cardiac surgery performed via median sternotomy

Age 18 years and older

Must not have

Prior or current lung transplant patients

Refusal to be consented

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 96 hours postoperatively or until discharge from the intensive care unit (icu), whichever came first.

Awards & highlights

No Placebo-Only Group

Summary

This trial will compare three different types of therapies to see which is best at expanding lungs and improving recovery after surgery.

Who is the study for?

This trial is for adults over 18 who are in the Cardiovascular ICU after certain heart surgeries like bypass or valve repair. They must have had their surgery through a cut down the middle of the chest. It's not for those with a BMI over 40, those who don't consent to participate, or patients with past or current lung transplants.

What is being tested?

The study is comparing three breathing treatments—IPPB, EzPAP, and Metaneb—to see which one helps lungs recover better after heart surgery. Patients will be randomly assigned to receive one of these therapies as they recuperate.

What are the potential side effects?

Potential side effects from these respiratory therapies may include discomfort while using the devices, possible shortness of breath during treatment, and rarely some might experience increased pressure in the lungs.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I had heart surgery through a cut down the center of my chest.

Select...

I am 18 years old or older.

Select...

I was admitted to the CVICU after heart surgery.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have had a lung transplant.

Select...

I do not agree to participate in this study.

Select...

My BMI is over 40.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 96 hours postoperatively or until discharge from the intensive care unit (icu), whichever came first.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 96 hours postoperatively or until discharge from the intensive care unit (icu), whichever came first.

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 96 hours postoperatively or until discharge from the intensive care unit (icu), whichever came first. for reporting.